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Abstract
Background: Mycoplasma hyorhinis infection has been postulated to play a role in the development of several
types of cancer, but the direct evidence and mechanism remained to be determined.
Methods: Immunohistochemistry assay and nested polymerase-chain reaction (PCR) were performed to examine
the mycoplasma hyorhinis infection in gastric cancer tissues. Statistical analysis was used to check the association
between mycoplasma infection and clinicopathologic parameters. Transwell chamber assay and metastasis assay
were used to evaluate mycoplasma hyorhinis’ effects on metastasis in vitro and in vivo. Mycoplasma hyorhinis-
induced extracellular signal-regulated kinase (ERK) and epidermal growth factor receptor (EGFR) activation were
investigated by Western blot.
Results: Mycoplasma hyorhinis infection in gastric cancer tissues was revealed and statistical analysis indicated a
significant association between mycoplasma infections and lymph node metastasis, Lauren’s Classification, TNM
stage, and age of the patients. Mycoplasma hyorhinis promoted tumor cell migration, invasion and metastasis in
vitro and in vivo, which was possibly associated with the enhanced phosphorylation of EGFR and ERK1/2. The
antibody against p37 protein of Mycoplasma hyorhinis could inhibit the migration of the infected cells.
Conclusions: The infection of mycoplasma hyorhinis may contribute to the development of gastric cancer and
Mycoplasma hyorhinis-induced malignant phenotypes were possibly mediated by p37.
Background
Mycoplasma is one of the smallest living organisms
isolated from nature, and can be cultured in a special
medium. Three independent groups [1-3] had
described Mycoplasma hyorhinis infection using PCR
and enzyme-linked immunosorbent assay (ELISA) in
gastric cancer, cervical condyloma tissues and ovarian
cancer. Mycoplasma sp. infection was also documented
in conventional renal cell carcinoma [4]. Our previous
work demonstrated high infection rate of mycoplasma
hyorhinis in gastric cancer tissues by immunohisto-
chemistry (IHC) with PD4 monoclonal antibody
against P37 protein of Mycoplastma hyorhinis.
Mechanistically, mycoplasmal infection was found to
inhibit apoptosis and induce malignant transformation
of murine myeloid 32D cells [5]. We recently revealed
that p37 promoted tumor cell motility, migration and
invasion in vitro and enhanced tumor cell metastasis
in C57BL/6 mice, which was mainly mediated by
matrix metalloproteinase-2 (MMP-2) and the EGFR/
MEK/ERK pathway [6]. Exogenous p37 protein was
also found to alter gene expression profile, growth rate
and morphology of prostate cancer cells [7]. All of
these results suggest a possible link between myco-
plasma infection and tumorigenesis, but the direct evi-
dence remains elusive. In this study, the presence and
the clinical significance of mycoplasma hyorhinis infec-
tion in gastric carcinoma tissues were analyzed with
nested PCR and IHC assay. Meanwhile, the biological
effects of mycoplasma hyorhinis infection on gastric
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Methods
Cells and materials
T h eh u m a nM G C 8 0 3g a s t r i cc a r c i n o m ac e l l s ,d e r i v e d
from a poorly differentiated gastric cancer surgical spe-
cimen [8], were cultured in RPMI-1640 medium with
10% FCS. Human AGS gastric cancer cells and mouse
B16F10 melanoma cells (both from American Type Cul-
ture Collection) were cultured in F-12 and RPMI-1640
medium plus 10% FCS, respectively. All culture media
were from Invitrogen (Carlsbad, CA, USA). PD4, a
mouse monoclonal antibody against p37 of Mycoplasma
hyorhinis, was generated and characterized by our
laboratory [9]. Pan-specific anti-mycoplasma antibody
was a gift from the Beijing Institute of Basic Medical
Sciences (Beijing, China). Transwell chambers (24-well)
with 8.0-μm pore membranes were purchased from
Corning (New York, NY, USA). Matrigel gel was pur-
chased from Becton Dickinson (Franklin Lakes, NJ,
USA). Antibodies to EGFR, pEGFR, ERK1/2 and
pERK1/2 were purchased from Santa Cruz Biotechnol-
o g y( S a n t aC r u z ,C A ,U S A ) .H o r s e r a d i s hp e r o x i d a s e
(HRP)-coupled goat anti-mouse IgG and goat anti-rabbit
IgG were from Zhongshan Biotechnology Company
(Beijing, PR China).
Gastric carcinoma specimens
Sixty-one freshly resected specimens from patients with
gastric carcinoma were collected in the Beijing Cancer
Hospital (Beijing, China). Informed consent was
obtained from each patient and the study was approved
and supervised by the Medical Ethics Committee of
Peking University Cancer Hospital & Institute. Within
30 minutes of removal, cancer tissues (~0.5 cm
3)w e r e
transported to laboratory in an icebox and processed on
a petri dish in the fume hood by washing with 15 ml
ice-cold phosphate-buffered saline (PBS) for three times,
followed by slicing into 1 mm
3 cubes with a sterilized
scissor. The sliced samples were then kept in cryo tubes
and frozen at -80°C for later isolation of DNA.
Preparation of conditional medium and Mycoplasma
hyorhinis infection
Cell culture supernatant of MGC803 cells-infected by
Mycoplasma hyorhinis was centrifuged at 3000 rpm for
5 min to remove cell debris, followed by centrifugation
at 12,000 rpm for 1 hour. The pellet containing Myco-
plasma hyorhinis was diluted with fresh medium and
added to AGS cells culture for infection. After two
weeks, efficiency of infection was verified by Western
blot with PD4 antibody.
Detection of Mycoplasma hyorhinis DNA with nested PCR
Total DNA was isolated from 10 mg of previously frozen
gastric cancer tissue by digestion overnight in 0.5%
Tween-20, 50 mM Tris (pH 8.5), 1 mM EDTA, and 200
mg/L proteinase K, followed by phenol/chloroform/isoa-
myl alcohol extraction and sodium acetate precipitation.
DNA precipitates were washed with 70% ethanol, dried,
and dissolved in 20 μL sterile H2O. A nested PCR kit
(Clone-Gen; Wuxi Institute for Clone Genetic Technol-
ogy, Jiangsu Province, PR China) was used according to
the manufacturer’s instructions to detect different myco-
plasmas, including Mycoplasma hyorhinis and Myco-
plasma fermentans. The nested PCR was performed with
1t o2μL of extracted DNA (~0.5 μg) from the tissues.
The DNA was added to 15 μL of the reaction solution,
including a pair of universal mycoplasmal primers (P1: 5’-
ACACCATGGGAGCTGGTAAT-3’, P2: 5-CTTCATC-
GACTTTCAGACCCAAGGCAT-3), dNTPs, Taq DNA
polymerase, and PCR buffer, to a total volume of 25 μL.
The DNA was denatured at 94°C for 2 min first, and then
93°C for 30 s, 55°C for 30 s, and 72°C for 60 s for 35 cycles
and finally at 72°C for 10 min. The first PCR product was
diluted 10 folds, and 5 μL of the diluted product was used
as a template. A second sets of specific mycoplasmal pri-
mers annealing to gene sequences coding for evolutiona-
rily conserved 16S rRNA of different mycoplasma species
(Mycoplasma hyorhinis:P 1 : 5 ’-CAAGATAAAAT-
CATTTCCT-3’, P2:5-AGTAATAGAAAGGAGCTTC-3;
Mycoplasma fermentans:P 1 : 5 ’-GAAGCCTTTCTT
CGCTGGAG-3’,P 2 :5 ’-ACAAAATCATTTCCTATT
CTGTC-3’) were used with the same amplification condi-
tions as described above. An internal control was intro-
duced to exclude any false-negative test resulting from
artificial causes. The PCR products were analyzed by agar-
ose gel electrophoresis and DNA sequencing.
Immunohistochemistry staining
Paraffin-embedded gastric tumor tissues were obtained
from Department of Pathology of Peking University
Cancer Hospital & Institute (Beijing, PR China). The
tissue sections were stained with a pan-specific anti-
mycoplasma antibody by IHC techniques according to
the standard protocol [10] and the results were judged
by two pathologists independently. (-) means no staining
was observed in cells, (+) means less than 50% cells
w e r eo b s e r v e dt ob es t a i n e d ,a n d( + + )i n d i c a t e st h a t
over 50% cells were stained. Normal mouse IgG was
used as a negative control.
Cell colony-forming assay
500-1000 indicated cells were cultured per well in six
well plates. After 5 to 10 days, the cell colonies were
fixed in acetone-methanol (1:1) and stained with 5%
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each aggregates or colonies which were visible by naked
eyes) were counted.
Cell migration and invasion assay
Cell migration assay was performed by using culture med-
ium-treated 6.5 mm Transwell chamber with 8.0 μmp o l y -
carbonate membranes. According to the previous method
[11], the bottom chamber was filled with 800 μL medium
containing 10% FCS. Cells were harvested from tissue cul-
ture plates by serum-free medium, and then were seeded
onto the top chamber of each Transwell at a density of
2×10
5-1×10
6 cells/mL/well (100 μL/chamber) in serum-
free medium. After incubation in a humidified incubator
with 5% CO2 at 37°C for 24 hours, non-migratory cells
were scraped off from the top of the Transwell with a cot-
ton swab. The cells attached to the bottom side of the
membrane were fixed by methanol, stained with 5% crystal
violet, and counted under a light microscope.
The invasion assay was similar to the migration assay
described above, except that the upper side of the mem-
branes was coated with a uniform thickness (2 mm) of
100 μg Matrigel for 60 min at room temperature (RT)
before the cells were added.
Cell migration inhibition assay
The assay of migration inhibition was similar to the
migration procedure described above, except that
MGC803 cells were seeded onto the top chamber of each
Transwell and different concentrations of normal rabbit
IgG, rabbit anti-GST or rabbit anti-p37 antibody were
added simultaneously. The concentrations of antibody
were 20 μg, 50 μg, 100 μg or 200 μg per mL, respectively.
Metastasis assay in vivo
The animal experiments were approved and supervised
by the Medical Ethics Committee of Peking University
Cancer Hospital & Institute. Female C57BL/6 mice
(Vital River Laboratories, Beijing, PR China) were main-
tained under a germ-free conditions in the animal facil-
ity and used at 8-10 weeks of age, weighed 18-20 g.
Uninfected or Mycoplasma hyorhinis-infected B16F10
cells were injected into C57BL/6 mice via tail lateral
vein (2 × 10
5 cells per recipient) respectively. After 25
days, mice were sacrificed. The weight of lung was
weighed and the number of metastatic tumor foci on
the surface of mice’s lung was counted. Meanwhile, the
metastatic foci on livers and kidneys were also checked.
Western blot analysis
To assess the effect of Mycoplasma hyorhinis on EGFR
and ERK activation, cells were washed with PBS and
harvested by centrifugation. Cells lysates were prepared
as described previously [12]. Equal aliquot of the total
protein were separated by SDS-PAGE and transferred
onto nitrocellulose membrane. The membranes were
probed with antibodies to pEGFR or pERK1/2 and
HRP-conjugated IgG as secondary antibody. The
enhanced chemiluminesence (ECL) system (Amersham-
Pharmacia, NJ, USA) was employed in this experiment.
The same membrane was then stripped and reprobed
with anti-EGFR or ERK1/2 antibody to determine the
total protein abundance.
Statistical analysis
T h ed a t aw e r ea n a l y z e du s i n gt h ec2 test by SPSS 13.0
software (SPSS) and P < 0.05 was considered significantly.
Results
Mycoplasma infection in gastric carcinoma tissues
To detect Mycoplasma hyorhinis infection in gastric
cancer tissues, a nested PCR assay was performed.
Thirty-nine samples (39/61, 63.9%) were positive for
Mycoplasma hyorhinis; among them, nineteen (19/61,
31.1%) were also positive for Mycoplasma fermentans
(Figure 1A). This finding was confirmed by sequencing
of the PCR-amplified DNA sequences (data not shown).
Statistical analysis of the relationship between PCR
results and the data of clinical pathology and follow-up
revealed that there was a significant association between
mycoplasma infections, lymph node metastasis, Lauren’s
Classification, TNM stage and age of the patients (P <
0.05) (Table 1). There was more lymph node metastasis
in mycoplasma infection group than in non-infected
group. More mycoplasma infection was observed in dif-
fuse-type gastric carcinoma than in the intestinal-type.
The infection rate of mycoplasma in TNM stage III/IV
was higher than in stage I/II. In addition, older patients
were prone to be infected by mycoplasma.
To further confirm the presence of mycoplasmas in
gastric cancer tissues, we performed IHC staining on
paraffin-embedded specimens from the same 61 patients
using a pan-specific antibody against mycoplasma.
Twenty-eight primary tumors (28/61, 45.9%) were
scored as positive for mycoplasmas, 25 of which had
also been found to be positive according to the results
of nested PCR. Stained as brown granules, the myco-
plasmas were localized mainly in the cytoplasm of can-
cer cells, as shown in Figure 1B.
Mycoplasma hyorhinis promotes tumor cell colony
formation, migration, and invasion in vitro
After confirming Mycoplasma hyorhinis infection in gas-
tric cancer tissues, we used the Mycoplasma hyorhinis
to infect gastric cancer cell lines MGC803 and AGS to
investigate the effects of the infection on these cells.
After confirming the expression of p37 protein in
infected MGC803 and AGS cells by Western blot
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More colonies were formed in infected cells than in
non-infected cells (P < 0.05) (Figure 2B). Our previous
study showed that p37 enhanced cancer cell migration
and invasion in vitro [6]. Because p37 is a membrane
lipoprotein of Mycoplasma hyorhinis, we predicted that,
as the intact pathogen, Mycoplasma hyorhinis may have
similar effects on such phenotypes. To test this, a modi-
fied Transwell chamber assay was employed and the
result showed that cells’ capacities of migration and
invasion were significantly increased upon infection
(P < 0.05) (Figure 3A,B).
Mycoplasma hyorhinis stimulates cancer cell metastasis in
C57BL/6 mice
Next, in vivo metastasis assay was performed to better
substantiate results from in vitro studies. However, AGS
cells were poor in forming tumors in mice and
MGC803 cells’ metastasis potential was low (data not
shown). In the previous study we had used p37 adeno-
virus-infected B16F10 melanoma to examine the
Figure 1 Mycoplasma infection in gastric cancer tissues. A. Nested PCR of mycoplasmal DNA amplified from human gastric cancer tissues.
Universal primers were used for the first round PCR and Mycoplasma hyorhinis-specific primers or Mycoplasma fermentans-specific primers for
second round PCR to amplify the mycoplasmal DNA. Lanes 1 and 2 are positive and negative controls, respectively. Lanes 5, 9, 14, 18, and 24
show results from tissues from which both Mycoplasma hyorhinis and Mycoplasma fermentans DNA were amplified. Lanes 13, 15, 17, 19, and 23
show results from tissues from which only Mycoplasma hyorhinis DNA was amplified. B. IHC staining of gastric cancer tissues with a pan-specific
anti-mycoplasma antibody (400 ×). (a, b, c) well-differentiated, moderately differentiated and poorly differentiated adenocarcinomas, respectively.
(d) mucous adenocarcinoma. (e) lymph node metastasis of moderately differentiated adenocarcinoma. (f) control staining with IgG.
Table 1 Detection of Mycoplasma DNA from Gastric
Carcinoma Tissues by Nest- PCR and its correlation with
clinicopathologic characteristics
Differences Correlation
c2 value P value R value P value
Lauren’s Classification 5.584 0.018 0.303 0.018
lymph node metastasis 3.832 0.05 0.251 0.051
TNM stage 5.294 0.021 0.295 0.021
age 15.398 0.000 0.447 0.000
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Herein similar approach was utilized. B16F10 cells were
infected by Mycoplasma hyorhinis, which was verified by
the expression of p37 protein (Figure 4A). The infected
and uninfected B16F10 cells were injected into C57BL/6
mice via tail lateral vein, respectively. After twenty-five
days, the number of metastatic lesions in the lung and
liver of mice were counted. The metastatic foci in the
lung increased significantly (Figure 4B,C; P < 0.05), but
no difference in the weight of lungs was observed
(Figure 4D) and no metastatic foci were formed in the
livers or kidneys (data not shown). We then concluded
that Mycoplasma hyorhinis infection stimulates tumor
metastasis in C57BL/6 mice.
Mycoplasma hyorhinis promotes phosphorylation of EGFR
and ERK1/2
The p37-promoted the phosphorylation of EGFR and
ERK1/2 has been noticed in our previous work [6],
which may contribute to Mycoplasma hyorhinis infec-
tion-related phenotype. We examined the expression of
pEGFR and pERK in Mycoplasma hyorhinis-infected
MGC803 and AGS cells. The result showed that phos-
phorylation of both EGFR and ERK1/2 was substantially
enhanced. Therefore Mycoplasma hyorhinis infection
could activate EGFR and ERK1/2 (Figure 5).
Antibody against p37 abrogates Mycoplasma hyorhinis-
induced cell migration
Although previous study suggested that p37 may facili-
tate Mycoplasma hyorhinis-induced tumor cell invasion,
whether the invasion of tumor cell was directly
mediated by p37 is unknown. We then performed a
migration inhibition assay. As shown in Figure 6, the
migration ability of Mycoplasma hyorhinis-infected cells
was reduced dramatically after being treated with the
antibody against p37 (≧50 μg/mL), but the normal rab-
bit antibody and GST antibody had no effect, even at
high concentration (up to 200 μg/mL, P < 0.05),
Figure 2 Mycoplasma hyorhinis promotes colony formation of
cancer cells. A. Verification of Mycoplasma hyorhinis infection.
Mycoplasma-infected (+) and non-infected (-) MGC803 and AGS
cells were harvested and cell lysates were subjected to Western blot
analysis with PD4 antibody against p37 protein. Purified p37 protein
[6] was used as positive control. B. Colony formation assay. 500-
1000/well cells were cultured in 6 well plates for 5-10 days. The cell
colonies were fixed by acetone-methanol (1:1) and stained with
Crystal Violet. The numbers of colonies were counted and the
graphs were the composite results from three independent
experiments. There were more colonies in infected cells than non-
infected cells (P < 0.05).
Figure 3 Mycoplasma hyorhinis promotes migration and
invasion. 2×1 0
4-1 × 10
5 cells were cultured in the top chamber
of Transwell for 24-36 hours. After removing the cells on the top
with a cotton swab, the cells attached on the bottom side of the
membrane were fixed by methanol, stained with 5% crystal violet.
The number of cells was counted. The graphs were the composite
results from three independent experiments. A. Migration of
uninfected cells (-) or infected cells (+). B. Invasion of uninfected
cells (-) or infected cells (+). The number of migration cells and
invasion cells of infected group were higher than those of
uninfected group (P < 0.05).
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was directly mediated by p37 protein.
Discussion
Our previous work showed that there was high inci-
dence of mycoplasma infection in gastric cancer tissues
by IHC, which suggests a possible association between
mycoplasma infection and tumorigenesis [13]. In the
present study, we demonstrated the presence of myco-
plasma in gastric cancer tissues through two indepen-
dent methods: nested PCR assay and IHC staining.
Positive correlation among different experimental meth-
ods confirmed that Mycoplasma hyorhinis and Myco-
plasma fermentans were indeed positive in gastric
carcinoma. Interestingly, we found that Mycoplasma fer-
mentans infection in gastric cancer tissues was always
accompanied by Mycoplasma hyorhinis infection, but
Mycoplasma hyorhinis infection could exist independent
of Mycoplasma fermentans. Therefore the result pro-
vides the first direct evidence of the presence of Myco-
plasma hyorhinis in human gastric tumor tissues. We
also analyzed the results of PCR detection (61 cases)
with clinicopathologic data and noticed that myco-
plasma infection had a close relationship with the lymph
node metastasis, Lauren’s Classification, TNM stage and
age (P < 0.05). Compared to IHC, PCR possesses higher
sensitivity, so the result of PCR may be more reliable to
investigate the relationship between mycoplasma infec-
tion and gastric cancer’s clinical manifestation and
prognosis.
Long-term mycoplasma infection of cultured cells was
associated with chromosomal instability and promoted
malignant transformation [5,14,15]. Persistent infections
with mycoplasma genitalium and mycoplasma hyorhinis
induced malignant transformation of benign human pros-
tate cells BPH-1 and increase migration and invasion [16].
Moreover, mycoplasma infection reduced p53 activation,
activated NF-B and cooperated with oncogenic Ras in
the transformation of rodent fibroblast [17]. p37 is part of
a homologous, high-affinity transport system on the mem-
brane of Mycoplasma hyorhinis [18,19]. Other studies
showed that p37 enhances tumor cell invasion in vitro
[20-22], inhibits mammalian cell adhesion [12], and
induces secretion of TNF-a from human peripheral blood
mononuclear cells [23-25]. Recently, we demonstrated
that p37 may promote gastric cancer cell invasion and
metastasis by increasing the activity of MMP-2 and by
inducing EGFR phosphorylation, therefore contributing to
Figure 4 Mycoplasma hyorhinis stimulates tumor metastasis in C57BL/6 mice. A. Verification of Mycoplasma hyorhinis infection in B16F10
cells by Western blot with PD4 antibody. B. Macroscopic documentation of lung metastasis lesions of mice injected with infected (+) or
uninfected (-) B16F10 cells. C. The average numbers of metastatic lesions for each mouse. The infected group had more metastasis than the
uninfected group (P < 0.05). D. The average weight of lungs of mice injected with B16F10 cells. No difference was observed (P > 0.05)
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[6]. Based on these findings, herein we analyzed the phe-
notypes of MGC803 and AGS cells infected with Myco-
plasma hyorhinis, and the results indicated that
mycoplasma hyorhinis could also promote tumor cell
migration and invasion in vitro and in vivo.
Blocking antibodies had been utilized to study the phe-
notypes of mycoplasma-infected cells. Dudler et al [18]
revealed that MAb DD9 treatment could alter the myco-
plasma metabolism and indirectly modify their interac-
tion with the host cells. Moreover, MAb 243-5 was
reported to reduce the lung metastasis of colon cancer in
t h en u d em i c em o d e l[ 1 9 ] .T h i sa n t i b o d yc o u l ds p e c i f i -
cally recognize a mycoplasmal protein with an MW of 47
kDa, which was obtained by immunization with Myco-
plasma arginini-infected RPMI 4788 cells. PD4, a specific
monoclonal antibody against p37, inhibited tumor-
growth of MGC-803 cells in nude mice by inducing
apoptosis and the proliferation of Ras-transformed cells
[8,26,27]. Although Mycoplasma hyorhinis and p37 had
long been predicted to be associated with increased inva-
siveness and tumor metastasis [6,19,21,22,28-30], the
direct evidence, of which Mycoplasma hyorhinis promot-
ing tumor cell invasion through the p37 protein, was
missing. Our present work showed that Mycoplasma
hyorhinis could promote tumor cell colony formation,
migration and invasion. Furthermore, antibody against
p37 inhibited the migration of Mycoplasma hyorhinis-
infected tumor cells. These results suggested p37 is a cri-
tical molecule mediating Mycoplasma hyorhinis infection
and promoting cell migration.
Conclusions
In summary, we have successfully detected Mycoplasma
hyorhinis and Mycoplasma fermentans in gastric cancer
tissues, and for the first time, found the correlation
between mycoplasma infection and clinicopathologic
characteristics for gastric cancer patients. p37 is critical
for promoting cancer cells’ malignant phenotypes. Our
present works reveal the potential roles of mycoplasma
infection in gastric cancer development and highlight
the close relationships among Mycoplasma hyorhinis
infection, p37 and tumorigenesis.
Acknowledgements
We thank Drs Jiyou Li, Jiafu Ji, Jianping Sun (Peking University Cancer
Hospital & Institute) for providing the gastric cancer tissues. We also thank
Beijing Institute of Basic Medical Sciences for providing pan-specific anti-
mycoplasma antibody. This work was supported by National Nature Science
Foundation of China (30130190) to CS and National 973 Program of China
(2009CB521805) to CS.
Author details
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of
Education), Department of Biochemistry and Molecular Biology, Peking
University Cancer Hospital & Institute, Beijing 100142, PR China.
2Current
address: Medical Testing College, Ningxia Medical University, Yinchuan
750004, PR China.
3Department of General Surgery, Beijing Chaoyang
Hospital, Beijing 100043, PR China.
4Current address: Department of Health
Science and Nursing, Wuhan Polytechnic University, Wuhan 430023, PR
China.
Authors’ contributions
CS conceived and supervised the project; CS, LQ and HY designed the
experiments; HY, HM, LC, WL, CL, LM and JW performed the experiments
and collected data; CS, LQ and HY analyzed data; HY, LQ and CS wrote the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Figure 5 Mycoplasma hyorhinis stimulates EGFR and ERK1/2
phosphorylation in gastric cancer cells. Lysates from Mycoplasma
hyorhinis infected MGC803 (left panel) and AGS cells (right panel)
were subjected to Western blot analysis with antibodies against
pEGFR, EGFR, pERK1/2 and ERK1/2.
Figure 6 Antibody against p37 blocks Mycoplasma hyorhinis-
promoted cell migration. Infected MGC803 cells were treated with
indicated concentration of normal rabbit IgG, rabbit anti-GST or
rabbit anti-p37 antibody, followed by Transwell chamber migration
assay. Antibody against p37 inhibited Mycoplasma hyorhini-
promoted migration with a dose-dependent manner (P < 0.05).
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